首页> 外文期刊>Diabetes/metabolism research and reviews >SUMO4 and its role in type 1 diabetes pathogenesis.
【24h】

SUMO4 and its role in type 1 diabetes pathogenesis.

机译:SUMO4及其在1型糖尿病发病机理中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Susceptibility to type 1 diabetes (T1D) is determined by interactions of multiple genes with unknown environmental factors. Despite the characterization of over 20 susceptibility regions for T1D, identification of specific genes in these regions is still a formidable challenge. In 2004, we first reported the cloning of a novel, small ubiquitin-like modifier (SUMO) gene, SUMO4, in the IDDM5 interval on chromosome 6q25, and presented strong genetic and functional evidence suggesting that SUMO4 is a T1D susceptibility gene. Subsequent studies have consistently confirmed this association in multiple Asian populations despite controversial observations in Caucasians. In this review, we will update the genetic evidence supporting SUMO4 as a T1D susceptibility gene and discuss the possible explanations for the discrepant associations observed in Caucasians. We will then discuss the mechanisms through which SUMO4 contributes to the pathogenesis of T1D.
机译:1型糖尿病(T1D)的易感性是由多个基因与未知环境因素的相互作用决定的。尽管对T1D敏感的区域超过20个,但在这些区域中鉴定特定基因仍然是一个艰巨的挑战。 2004年,我们首次报道了在染色体6q25的IDDM5区间克隆了一个新的小的泛素样修饰子(SUMO)基因SUMO4,并提供了强有力的遗传和功能证据,表明SUMO4是T1D易感基因。尽管在高加索人中观察到有争议的结果,但随后的研究一致地在多个亚洲人口中证实了这种关联。在这篇综述中,我们将更新支持SUMO4作为T1D易感性基因的遗传证据,并讨论在白种人中观察到的差异关联的可能解释。然后,我们将讨论SUMO4参与T1D发病机理的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号